万孚生物：10月24日召开董事会会议

Group 1 - The core point of the article is that Wanfu Biology (SZ 300482) held its 16th meeting of the 5th Board of Directors on October 24, 2025, to review proposals including amendments to the company's articles of association and related rules [1] - For the fiscal year 2024, the revenue composition of Wanfu Biology is reported to be 97.59% from diagnostic products and 2.41% from other sources [1] - As of the time of reporting, Wanfu Biology has a market capitalization of 10.3 billion yuan [1]